The Long Shadow of MAPS; Ups and Downs of a Retail Investor Base; Safety Four Ways
4
1
This week we’re looking at a few developments that occupy what we might call the “infrastructure and operational” layer required for…
9
Hello! On the occasion of my recent appearance on the Business Trip Podcast, where I spoke with Greg Kubin of the Psychedelic Medicine Syndicate, I…
6
Part 1: Direct-to-Consumer healthcare & Decentralized Clinics
7
This week we’re looking at: The results and implications of the first controlled trial of psilocybin-assisted therapy for heavy drinking Recent findings…
3
1
Happy Friday to those who celebrate. For those with young children, happy Monday. In today’s dispatch, we’re taking a look at the following: Alberta’s…
6
Part II of the Unbundling Psychedelic Therapy series
7
2
Today we’re looking at the recent psychedelic-related election results from Colorado and Oregon. Voters in Colorado approved Prop 122, which…
2
There were several developments this week worth touching on: MindMed was awarded a patent for the combination of MDMA and LSD—commonly called…
3
Part IIIa of the Unbundling Psychedelic Therapy Series
4
1
In any given week, some development in the psychedelic space—a scientific study, a company announcement, or policy development—will completely take over…
4
1
Today we are looking at A Review of a paper on Psychedelic-Induced Neuroplasticity A look ahead at the inaugural The Trip Report Live, a panel…
5